| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.16B | 1.09B | 912.80M | 740.79M | 590.95M | 468.36M |
| Gross Profit | 245.42M | 232.80M | 202.80M | 149.22M | 110.19M | 103.33M |
| EBITDA | 134.24M | 124.40M | 103.70M | 78.61M | 57.69M | 46.17M |
| Net Income | 57.65M | 47.90M | 39.30M | 36.80M | 30.40M | 38.90M |
Balance Sheet | ||||||
| Total Assets | 975.60M | 916.60M | 839.10M | 533.84M | 502.02M | 412.50M |
| Cash, Cash Equivalents and Short-Term Investments | 27.70M | 37.70M | 29.80M | 22.44M | 29.03M | 36.50M |
| Total Debt | 211.80M | 212.50M | 183.80M | 125.88M | 124.08M | 63.80M |
| Total Liabilities | 553.10M | 546.40M | 503.50M | 301.73M | 294.05M | 228.50M |
| Stockholders Equity | 412.70M | 361.00M | 327.20M | 224.73M | 200.59M | 184.00M |
Cash Flow | ||||||
| Free Cash Flow | 51.18M | 31.20M | 46.70M | 38.64M | 3.46M | 32.65M |
| Operating Cash Flow | 87.93M | 77.30M | 78.30M | 57.39M | 17.88M | 40.89M |
| Investing Cash Flow | -49.69M | -55.10M | -167.30M | -30.85M | -66.73M | -52.40M |
| Financing Cash Flow | -29.81M | -15.00M | 95.50M | -32.18M | 38.85M | 15.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £1.06B | 7.96 | 14.90% | 1.11% | 8.19% | 25.78% | |
78 Outperform | £315.95M | 9.77 | 20.71% | 3.92% | 11.92% | 41.55% | |
64 Neutral | £292.21M | 8.85 | 13.58% | 2.58% | -2.13% | 3.94% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £117.52M | 8.71 | -31.80% | ― | -5.72% | ― | |
56 Neutral | £403.37M | -21.41 | -6.50% | ― | -6.96% | -1.58% | |
50 Neutral | £7.07M | -9.55 | -2.20% | ― | -8.49% | -7.32% |